Apr 29, 2025 / 09:00AM GMT
Fredrik Dahl Devyser Diagnostics AB-Interim CEO
Good day and welcome to the Devyser Q1 2025 earnings call. I'm Fredrik Dahl, I'm the acting CEO of Devyser and would like to thank you everyone for joining our call today.
On the call today, we have, in addition to myself, also our CFO, Sabina Berlin and our Chief Commercial Officer, Theis Kipling.
I will start with a short summary of our quarterly results and then recap our updated strategy and present some highlights from the team before handing over to Sabina for more detailed review of our financial results in Q1 2025, and then to Theis for an update on our commercial activities.
We had another solid quarter based on revenue, the second strongest quarter in the history of the company. The revenue was SEK 55 million, representing a growth of 8% comparing, compared to Q1 last year. Gross margins were 83% and EBIT minus SEK 21 million.
Including SEK 8 million in one-offs related to reorg and another SEK 6 million in FX headwinds. Our cash position was SEK 114 million.
As mentioned on the previous call,
Q1 2025 Devyser Diagnostics AB Earnings Call Transcript
Apr 29, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers